Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases

Induced pluripotent stem cells (iPSCs) and induced neuronal (iN) cells are very much touted in terms of their potential promises in therapeutics. However, from a more fundamental perspective, iPSCs and iNs are invaluable tools for the postnatal generation of specific diseased cell types from patient...

Full description

Bibliographic Details
Main Author: Bor Luen Tang
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/7/5/38
_version_ 1797726673019338752
author Bor Luen Tang
author_facet Bor Luen Tang
author_sort Bor Luen Tang
collection DOAJ
description Induced pluripotent stem cells (iPSCs) and induced neuronal (iN) cells are very much touted in terms of their potential promises in therapeutics. However, from a more fundamental perspective, iPSCs and iNs are invaluable tools for the postnatal generation of specific diseased cell types from patients, which may offer insights into disease etiology that are otherwise unobtainable with available animal or human proxies. There are two good recent examples of such important insights with diseased neurons derived via either the iPSC or iN approaches. In one, induced motor neurons (iMNs) derived from iPSCs of Amyotrophic lateral sclerosis/Frontotemporal dementia (ALS/FTD) patients with a C9orf72 repeat expansion revealed a haploinsufficiency of protein function resulting from the intronic expansion and deficiencies in motor neuron vesicular trafficking and lysosomal biogenesis that were not previously obvious in knockout mouse models. In another, striatal medium spinal neurons (MSNs) derived directly from fibroblasts of Huntington’s disease (HD) patients recapitulated age-associated disease signatures of mutant Huntingtin (mHTT) aggregation and neurodegeneration that were not prominent in neurons differentiated indirectly via iPSCs from HD patients. These results attest to the tremendous potential for pathologically accurate and mechanistically revealing disease modelling with advances in the derivation of iPSCs and iNs.
first_indexed 2024-03-12T10:48:59Z
format Article
id doaj.art-da7dc6e4dde64205998d42c398f563f4
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T10:48:59Z
publishDate 2018-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-da7dc6e4dde64205998d42c398f563f42023-09-02T07:18:21ZengMDPI AGCells2073-44092018-05-01753810.3390/cells7050038cells7050038Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative DiseasesBor Luen Tang0Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, SingaporeInduced pluripotent stem cells (iPSCs) and induced neuronal (iN) cells are very much touted in terms of their potential promises in therapeutics. However, from a more fundamental perspective, iPSCs and iNs are invaluable tools for the postnatal generation of specific diseased cell types from patients, which may offer insights into disease etiology that are otherwise unobtainable with available animal or human proxies. There are two good recent examples of such important insights with diseased neurons derived via either the iPSC or iN approaches. In one, induced motor neurons (iMNs) derived from iPSCs of Amyotrophic lateral sclerosis/Frontotemporal dementia (ALS/FTD) patients with a C9orf72 repeat expansion revealed a haploinsufficiency of protein function resulting from the intronic expansion and deficiencies in motor neuron vesicular trafficking and lysosomal biogenesis that were not previously obvious in knockout mouse models. In another, striatal medium spinal neurons (MSNs) derived directly from fibroblasts of Huntington’s disease (HD) patients recapitulated age-associated disease signatures of mutant Huntingtin (mHTT) aggregation and neurodegeneration that were not prominent in neurons differentiated indirectly via iPSCs from HD patients. These results attest to the tremendous potential for pathologically accurate and mechanistically revealing disease modelling with advances in the derivation of iPSCs and iNs.http://www.mdpi.com/2073-4409/7/5/38induced pluripotent stem cells (iPSCs)induced neuronal (iN) cellsC9ORF72Huntingtinamyotrophic lateral sclerosis (ALS)Huntington’s diseaseneurodegenerative diseases
spellingShingle Bor Luen Tang
Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
Cells
induced pluripotent stem cells (iPSCs)
induced neuronal (iN) cells
C9ORF72
Huntingtin
amyotrophic lateral sclerosis (ALS)
Huntington’s disease
neurodegenerative diseases
title Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
title_full Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
title_fullStr Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
title_full_unstemmed Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
title_short Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
title_sort patient derived ipscs and ins shedding new light on the cellular etiology of neurodegenerative diseases
topic induced pluripotent stem cells (iPSCs)
induced neuronal (iN) cells
C9ORF72
Huntingtin
amyotrophic lateral sclerosis (ALS)
Huntington’s disease
neurodegenerative diseases
url http://www.mdpi.com/2073-4409/7/5/38
work_keys_str_mv AT borluentang patientderivedipscsandinssheddingnewlightonthecellularetiologyofneurodegenerativediseases